BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22571692)

  • 1. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V.
    Sánchez-Ferrero E; Coto E; Beetz C; Gámez J; Corao AI; Díaz M; Esteban J; del Castillo E; Moris G; Infante J; Menéndez M; Pascual-Pascual SI; López de Munaín A; Garcia-Barcina MJ; Alvarez V;
    Clin Genet; 2013 Mar; 83(3):257-62. PubMed ID: 22571692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia.
    Elleuch N; Depienne C; Benomar A; Hernandez AM; Ferrer X; Fontaine B; Grid D; Tallaksen CM; Zemmouri R; Stevanin G; Durr A; Brice A
    Neurology; 2006 Mar; 66(5):654-9. PubMed ID: 16534102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia.
    Arnoldi A; Tonelli A; Crippa F; Villani G; Pacelli C; Sironi M; Pozzoli U; D'Angelo MG; Meola G; Martinuzzi A; Crimella C; Redaelli F; Panzeri C; Renieri A; Comi GP; Turconi AC; Bresolin N; Bassi MT
    Hum Mutat; 2008 Apr; 29(4):522-31. PubMed ID: 18200586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort.
    van Gassen KL; van der Heijden CD; de Bot ST; den Dunnen WF; van den Berg LH; Verschuuren-Bemelmans CC; Kremer HP; Veldink JH; Kamsteeg EJ; Scheffer H; van de Warrenburg BP
    Brain; 2012 Oct; 135(Pt 10):2994-3004. PubMed ID: 22964162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A founder mutation p.H701P identified as a major cause of SPG7 in Norway.
    Rydning SL; Wedding IM; Koht J; Chawla M; Øye AM; Sheng Y; Vigeland MD; Selmer KK; Tallaksen CM
    Eur J Neurol; 2016 Apr; 23(4):763-71. PubMed ID: 26756429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects.
    Warnecke T; Duning T; Schirmacher A; Mohammadi S; Schwindt W; Lohmann H; Dziewas R; Deppe M; Ringelstein EB; Young P
    Mov Disord; 2010 Mar; 25(4):413-20. PubMed ID: 20108356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of paraplegin mutations by a yeast complementation assay.
    Bonn F; Pantakani K; Shoukier M; Langer T; Mannan AU
    Hum Mutat; 2010 May; 31(5):617-21. PubMed ID: 20186691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
    Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
    Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation.
    Warnecke T; Duning T; Schwan A; Lohmann H; Epplen JT; Young P
    Neurology; 2007 Jul; 69(4):368-75. PubMed ID: 17646629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands.
    Balicza P; Grosz Z; Gonzalez MA; Bencsik R; Pentelenyi K; Gal A; Varga E; Klivenyi P; Koller J; Züchner S; Molnar JM
    J Neurol Sci; 2016 May; 364():116-21. PubMed ID: 27084228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7.
    Estiar MA; Yu E; Haj Salem I; Ross JP; Mufti K; Akçimen F; Leveille E; Spiegelman D; Ruskey JA; Asayesh F; Dagher A; Yoon G; Tarnopolsky M; Boycott KM; Dupre N; Dion PA; Suchowersky O; Trempe JF; Rouleau GA; Gan-Or Z
    Mov Disord; 2021 Jul; 36(7):1664-1675. PubMed ID: 33598982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia.
    Battini R; Fogli A; Borghetti D; Michelucci A; Perazza S; Baldinotti F; Conidi ME; Ferreri MI; Simi P; Cioni G
    Eur J Neurol; 2011 Jan; 18(1):150-7. PubMed ID: 20550563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia.
    Wilkinson PA; Crosby AH; Turner C; Bradley LJ; Ginsberg L; Wood NW; Schapira AH; Warner TT
    Brain; 2004 May; 127(Pt 5):973-80. PubMed ID: 14985266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia.
    Dürr A; Camuzat A; Colin E; Tallaksen C; Hannequin D; Coutinho P; Fontaine B; Rossi A; Gil R; Rousselle C; Ruberg M; Stevanin G; Brice A
    Arch Neurol; 2004 Dec; 61(12):1867-72. PubMed ID: 15596607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus.
    Sauter SM; Engel W; Neumann LM; Kunze J; Neesen J
    Hum Mutat; 2004 Jan; 23(1):98. PubMed ID: 14695538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel compound heterozygous SPG7 mutations-related hereditary spastic paraplegia in a Chinese family: a case report.
    Zhang X; Zhang L; Wu Y; Li G; Chen S; Xia Y; Li H
    BMC Neurol; 2018 Nov; 18(1):196. PubMed ID: 30497413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.
    Namekawa M; Ribai P; Nelson I; Forlani S; Fellmann F; Goizet C; Depienne C; Stevanin G; Ruberg M; Dürr A; Brice A
    Neurology; 2006 Jan; 66(1):112-4. PubMed ID: 16401858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AAA ATPases and hereditary spastic paraplegia].
    Wang YG; Shen L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):298-301. PubMed ID: 19504443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
    Baviera-Muñoz R; Campins-Romeu M; Carretero-Vilarroig L; Sastre-Bataller I; Martínez-Torres I; Vázquez-Costa JF; Muelas N; Sevilla T; Vílchez JJ; Aller E; Jaijo T; Bataller L; Espinós C
    J Neurol Sci; 2021 Oct; 429():118062. PubMed ID: 34500365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients.
    Schlipf NA; Schüle R; Klimpe S; Karle KN; Synofzik M; Schicks J; Riess O; Schöls L; Bauer P
    Clin Genet; 2011 Aug; 80(2):148-60. PubMed ID: 21623769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.